KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,016 | -44.6% | 19,415 | +40.7% | 0.00% | – |
| Q4 2022 | $46,920 | -72.9% | 13,800 | -56.5% | 0.00% | – |
| Q3 2022 | $173,000 | -25.4% | 31,700 | -38.4% | 0.00% | – |
| Q2 2022 | $232,000 | -55.1% | 51,500 | -41.8% | 0.00% | -100.0% |
| Q1 2019 | $517,000 | -25.0% | 88,530 | +20.4% | 0.00% | 0.0% |
| Q4 2018 | $689,000 | +83.7% | 73,530 | +233.9% | 0.00% | 0.0% |
| Q3 2018 | $375,000 | -1.8% | 22,020 | -2.1% | 0.00% | 0.0% |
| Q2 2018 | $382,000 | -58.6% | 22,500 | -67.3% | 0.00% | 0.0% |
| Q1 2018 | $923,000 | +401.6% | 68,736 | +259.3% | 0.00% | – |
| Q4 2017 | $184,000 | – | 19,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |